These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1663450)

  • 1. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
    Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
    Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters.
    Fujiki H; Suganuma M; Yoshizawa S; Kanazawa H; Sugimura T; Manam S; Kahn SM; Jiang W; Hoshina S; Weinstein IB
    Mol Carcinog; 1989; 2(4):184-7. PubMed ID: 2508660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
    Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
    Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pathway of tumor promotion by the okadaic acid class compounds.
    Fujiki H; Suganuma M; Nishiwaki S; Yoshizawa S; Winyar B; Sugimura T; Schmitz FJ
    Adv Second Messenger Phosphoprotein Res; 1990; 24():340-4. PubMed ID: 2169814
    [No Abstract]   [Full Text] [Related]  

  • 5. Apparent "activation" of protein kinases by okadaic acid class tumor promoters.
    Sassa T; Richter WW; Uda N; Suganuma M; Suguri H; Yoshizawa S; Hirota M; Fujiki H
    Biochem Biophys Res Commun; 1989 Mar; 159(3):939-44. PubMed ID: 2930574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
    Newell SW; Perchellet EM; Gao XM; Chen G; Perchellet JP
    Cancer Lett; 1996 Jan; 98(2):241-51. PubMed ID: 8556715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
    Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
    Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship within a series of okadaic acid derivatives.
    Nishiwaki S; Fujiki H; Suganuma M; Furuya-Suguri H; Matsushima R; Iida Y; Ojika M; Yamada K; Uemura D; Yasumoto T
    Carcinogenesis; 1990 Oct; 11(10):1837-41. PubMed ID: 2170047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vimentin is hyperphosphorylated in primary human fibroblasts treated with okadaic acid.
    Yatsunami J; Fujiki H; Suganuma M; Yoshizawa S; Eriksson JE; Olson MO; Goldman RD
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1165-70. PubMed ID: 1647766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin.
    Fujiki H; Suganuma M; Suguri H; Yoshizawa S; Takagi K; Uda N; Wakamatsu K; Yamada K; Murata M; Yasumoto T
    Jpn J Cancer Res; 1988 Oct; 79(10):1089-93. PubMed ID: 3143697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Okadaic acid and dinophysistoxin-1, non-TPA-type tumor promoters, stimulate prostaglandin E2 production in rat peritoneal macrophages.
    Ohuchi K; Tamura T; Ohashi M; Watanabe M; Hirasawa N; Tsurufuji S; Fujiki H
    Biochim Biophys Acta; 1989 Sep; 1013(1):86-91. PubMed ID: 2506933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphosphorylation of cytokeratins by okadaic acid class tumor promoters in primary human keratinocytes.
    Yatsunami J; Komori A; Ohta T; Suganuma M; Yuspa SH; Fujiki H
    Cancer Res; 1993 Mar; 53(5):992-6. PubMed ID: 7679949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
    Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H
    J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mammalian ribonucleotide reductase by the tumor promoters and protein phosphatase inhibitors okadaic acid and calyculin A.
    Hurta RA; Wright JA
    Biochem Cell Biol; 1992; 70(10-11):1081-7. PubMed ID: 1338411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonphorbol tumor promoters okadaic acid and calyculin-A induce membrane translocation of protein kinase C.
    Gopalakrishna R; Chen ZH; Gundimeda U
    Biochem Biophys Res Commun; 1992 Dec; 189(2):950-7. PubMed ID: 1472068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
    Schönthal A; Alberts AS; Frost JA; Feramisco JR
    New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
    Suganuma M; Fujiki H; Suguri H; Yoshizawa S; Hirota M; Nakayasu M; Ojika M; Wakamatsu K; Yamada K; Sugimura T
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1768-71. PubMed ID: 3126494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1.
    Sakai A; Fujiki H
    Jpn J Cancer Res; 1991 May; 82(5):518-23. PubMed ID: 1905699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of okadaic acid, a new tumor promoter in mouse skin.
    Suganuma M; Suttajit M; Suguri H; Ojika M; Yamada K; Fujiki H
    FEBS Lett; 1989 Jul; 250(2):615-8. PubMed ID: 2546815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Okadaic acid-induced hyperphosphorylation of the epidermal growth factor receptor. Comparison with receptor phosphorylation and functions affected by another tumor promoter, 12-O-tetradecanoylphorbol-13-acetate.
    Hernández-Sotomayor SM; Mumby M; Carpenter G
    J Biol Chem; 1991 Nov; 266(31):21281-6. PubMed ID: 1657956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.